BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21194255)

  • 1. Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis.
    Nikeghbalian S; Pournasr B; Aghdami N; Rasekhi A; Geramizadeh B; Hosseini Asl SM; Ramzi M; Kakaei F; Namiri M; Malekzadeh R; Vosough Dizaj A; Malek-Hosseini SA; Baharvand H
    Arch Iran Med; 2011 Jan; 14(1):12-7. PubMed ID: 21194255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraportal Infusion of Bone Marrow Mononuclear or CD133+ Cells in Patients With Decompensated Cirrhosis: A Double-Blind Randomized Controlled Trial.
    Mohamadnejad M; Vosough M; Moossavi S; Nikfam S; Mardpour S; Akhlaghpoor S; Ashrafi M; Azimian V; Jarughi N; Hosseini SE; Moeininia F; Bagheri M; Sharafkhah M; Aghdami N; Malekzadeh R; Baharvand H
    Stem Cells Transl Med; 2016 Jan; 5(1):87-94. PubMed ID: 26659833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: A phase I clinical trial.
    Andreone P; Catani L; Margini C; Brodosi L; Lorenzini S; Sollazzo D; Nicolini B; Giordano R; Montemurro T; Rizzi S; Dan E; Giudice V; Viganò M; Casadei A; Foschi FG; Malvi D; Bernardi M; Conti F; Lemoli RM
    Dig Liver Dis; 2015 Dec; 47(12):1059-66. PubMed ID: 26427587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration.
    am Esch JS; Knoefel WT; Klein M; Ghodsizad A; Fuerst G; Poll LW; Piechaczek C; Burchardt ER; Feifel N; Stoldt V; Stockschläder M; Stoecklein N; Tustas RY; Eisenberger CF; Peiper M; Häussinger D; Hosch SB
    Stem Cells; 2005 Apr; 23(4):463-70. PubMed ID: 15790766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of autologous bone marrow-derived liver stem cells transplantation in hepatitis B virus-induced liver cirrhosis.
    Liao X; AnCheng JY; Zhou QJ; Liao C
    Hepatogastroenterology; 2013 May; 60(123):406-9. PubMed ID: 23178469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience.
    Fürst G; Schulte am Esch J; Poll LW; Hosch SB; Fritz LB; Klein M; Godehardt E; Krieg A; Wecker B; Stoldt V; Stockschläder M; Eisenberger CF; Mödder U; Knoefel WT
    Radiology; 2007 Apr; 243(1):171-9. PubMed ID: 17312278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.
    Mohamadnejad M; Alimoghaddam K; Mohyeddin-Bonab M; Bagheri M; Bashtar M; Ghanaati H; Baharvand H; Ghavamzadeh A; Malekzadeh R
    Arch Iran Med; 2007 Oct; 10(4):459-66. PubMed ID: 17903050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial.
    King A; Barton D; Beard HA; Than N; Moore J; Corbett C; Thomas J; Guo K; Guha I; Hollyman D; Stocken D; Yap C; Fox R; Forbes SJ; Newsome PN
    BMJ Open; 2015 Mar; 5(3):e007700. PubMed ID: 25795699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year follow-up of the local autologous transplantation of CD133+ enriched bone marrow cells in patients with myocardial infarction.
    Ahmadi H; Farahani MM; Kouhkan A; Moazzami K; Fazeli R; Sadeghian H; Namiri M; Madani-Civi M; Baharvand H; Aghdami N
    Arch Iran Med; 2012 Jan; 15(1):32-5. PubMed ID: 22208441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell therapy in chronic liver disease.
    Takami T; Terai S; Sakaida I
    Curr Opin Gastroenterol; 2012 May; 28(3):203-8. PubMed ID: 22395569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis.
    Kim JK; Kim SJ; Kim Y; Chung YE; Park YN; Kim HO; Kim JS; Park MS; Sakaida I; Kim DY; Lee JI; Ahn SH; Lee KS; Han KH
    Cell Transplant; 2017 Jun; 26(6):1059-1066. PubMed ID: 28120743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases.
    Salama H; Zekri AR; Zern M; Bahnassy A; Loutfy S; Shalaby S; Vigen C; Burke W; Mostafa M; Medhat E; Alfi O; Huttinger E
    Cell Transplant; 2010; 19(11):1475-86. PubMed ID: 20587151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease.
    Salama H; Zekri AR; Bahnassy AA; Medhat E; Halim HA; Ahmed OS; Mohamed G; Al Alim SA; Sherif GM
    World J Gastroenterol; 2010 Nov; 16(42):5297-305. PubMed ID: 21072892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis.
    Mohamadnejad M; Alimoghaddam K; Bagheri M; Ashrafi M; Abdollahzadeh L; Akhlaghpoor S; Bashtar M; Ghavamzadeh A; Malekzadeh R
    Liver Int; 2013 Nov; 33(10):1490-6. PubMed ID: 23763455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow derived stem cells for the treatment of end-stage liver disease.
    Margini C; Vukotic R; Brodosi L; Bernardi M; Andreone P
    World J Gastroenterol; 2014 Jul; 20(27):9098-105. PubMed ID: 25083082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of autologous bone marrow mononuclear cell transplantation in decompensated liver cirrhosis.
    Bai YQ; Yang YX; Yang YG; Ding SZ; Jin FL; Cao MB; Zhang YR; Zhang BY
    World J Gastroenterol; 2014 Jul; 20(26):8660-6. PubMed ID: 25024623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.
    Terai S; Ishikawa T; Omori K; Aoyama K; Marumoto Y; Urata Y; Yokoyama Y; Uchida K; Yamasaki T; Fujii Y; Okita K; Sakaida I
    Stem Cells; 2006 Oct; 24(10):2292-8. PubMed ID: 16778155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autologous bone marrow stem cell transplantation for treatment terminal liver diseases].
    Pan XN; Shen JK; Zhuang YP; Chen XL; Li YX; Chen LJ; Yang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1207-9. PubMed ID: 18676264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of autologous CD34-depleted bone marrow mononuclear cell transplantation via the hepatic artery in five patients with liver failure.
    Park CH; Bae SH; Kim HY; Kim JK; Jung ES; Chun HJ; Song MJ; Lee SE; Cho SG; Lee JW; Choi JY; Yoon SK; Han NI; Lee YS
    Cytotherapy; 2013 Dec; 15(12):1571-9. PubMed ID: 23849977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous bone marrow transplantation in decompensated liver: Systematic review and meta-analysis.
    Pankaj P; Zhang Q; Bai XL; Liang TB
    World J Gastroenterol; 2015 Jul; 21(28):8697-710. PubMed ID: 26229412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.